Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD63 (clone LAMP3/9Q6Z8P). We employs the Lentivirus (trc-Cy3-IL-10-EcoRI) vector components and the SynExpress system of the Exons Insertion/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD63
Clone
LAMP3/9Q6Z8P
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
trc
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Insertion
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.99
Cell Culture
Microcarrier Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.